Koninklijke Philips (NYSE:PHG) Shares Bought by Carmel Capital Partners LLC

Carmel Capital Partners LLC raised its position in Koninklijke Philips (NYSE:PHG) by 7.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,036 shares of the technology company’s stock after purchasing an additional 3,699 shares during the quarter. Carmel Capital Partners LLC’s holdings in Koninklijke Philips were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. FMR LLC increased its stake in shares of Koninklijke Philips by 0.6% in the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Koninklijke Philips by 315.0% in the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock valued at $8,040,000 after acquiring an additional 186,520 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Koninklijke Philips in the third quarter valued at approximately $4,622,000. Stifel Financial Corp boosted its holdings in shares of Koninklijke Philips by 16.4% in the third quarter. Stifel Financial Corp now owns 195,222 shares of the technology company’s stock valued at $6,388,000 after acquiring an additional 27,536 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Koninklijke Philips by 6.3% in the fourth quarter. GAMMA Investing LLC now owns 10,963 shares of the technology company’s stock valued at $278,000 after acquiring an additional 648 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 2.3 %

Koninklijke Philips stock opened at $27.16 on Thursday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. The firm has a market cap of $25.52 billion, a price-to-earnings ratio of -32.33, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a 1 year low of $19.10 and a 1 year high of $32.91. The firm’s 50 day moving average price is $26.44 and its two-hundred day moving average price is $28.01.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). The business had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, research analysts predict that Koninklijke Philips will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be given a $0.886 dividend. The ex-dividend date is Tuesday, May 13th. This represents a yield of 2.9%. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.

Analyst Upgrades and Downgrades

PHG has been the subject of several recent analyst reports. StockNews.com cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Friday, February 28th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Finally, UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.